What is the level of liabilities of Nanobiotix this year?
Nanobiotix has a debt balance of 95.74 M EUR this year.
Nanobiotix Liabilities 2024
Nanobiotix Liabilities
95.74 M EUR
Ticker
NANO.PA
ISIN
FR0011341205
WKN
A1J7EB
In 2024, Nanobiotix's total liabilities amounted to 95.74 M EUR, a 10.28% difference from the 86.81 M EUR total liabilities in the previous year.
Nanobiotix Aktienanalyse
What does Nanobiotix do?
Nanobiotix SA is a biotechnology company specializing in the development of nanoparticles used in cancer therapy to increase the effectiveness of radiation therapy. It was founded in 2003 in Paris, France by Dr. Laurent Lévy and his team. The company went public in 2012 and is currently listed on the Euronext Paris exchange. Nanobiotix's business model is based on the production and marketing of nanoparticles called NBTXR3, which enhance the effectiveness of radiation therapy. The company works with various partners to further develop its technology and explore new applications. Nanobiotix has two main divisions: one focused on developing nanoparticles to enhance radiation therapy for cancer, and another dedicated to using nanoparticles as drug carriers. Its flagship product, NBTXR3, is designed specifically for cancer therapy and has shown promising results. Nanobiotix is also working on combining NBTXR3 with immunotherapies to further improve cancer treatment. In summary, Nanobiotix is an innovative company specializing in the development of nanoparticles to enhance radiation therapy for cancer and improve patient treatment. Nanobiotix ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Nanobiotix's Liabilities
Nanobiotix's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Nanobiotix's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Nanobiotix's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Nanobiotix's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Nanobiotix’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Nanobiotix stock
What were the liabilities of Nanobiotix compared to the previous year?
The liabilities of Nanobiotix have increased by 10.28% increased compared to the previous year.
What are the consequences of high debt for investors of Nanobiotix?
High liabilities can pose a risk for investors of Nanobiotix, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Nanobiotix?
Low liabilities mean that Nanobiotix has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Nanobiotix affect the company?
An increase in liabilities of Nanobiotix can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Nanobiotix affect the company?
A decrease in the liabilities of Nanobiotix can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Nanobiotix?
Some factors that can influence the liabilities of Nanobiotix include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Nanobiotix so important for investors?
The liabilities of Nanobiotix are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Nanobiotix take to modify the liabilities?
To change its liabilities, Nanobiotix can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Nanobiotix pay?
Over the past 12 months, Nanobiotix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanobiotix is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nanobiotix?
The current dividend yield of Nanobiotix is .
When does Nanobiotix pay dividends?
Nanobiotix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nanobiotix?
Nanobiotix paid dividends every year for the past 0 years.
What is the dividend of Nanobiotix?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nanobiotix located?
Nanobiotix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nanobiotix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nanobiotix from 9/21/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.
When did Nanobiotix pay the last dividend?
The last dividend was paid out on 9/21/2024.
What was the dividend of Nanobiotix in the year 2023?
In the year 2023, Nanobiotix distributed 0 EUR as dividends.
In which currency does Nanobiotix pay out the dividend?
The dividends of Nanobiotix are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nanobiotix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nanobiotix
Our stock analysis for Nanobiotix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanobiotix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
